Cardinal Health, Inc. · NYSE:CAH
Cardinal Health — 43rd Annual J.P. Morgan Healthcare Conference 2025
19 slides from Cardinal Health's conference presentation, Jan 14, 2025
Slide 1: Cardinal Health, Inc. 43rd Annual JP Morgan Conference
Cardinal Health, Inc. 43rd Annual JP Morgan Conference January 14, 2025 © 2025 Cardinal Health. All Rights Reserved. 1 © 2025 Cardinal Health. All Rights Reserved.
Slide 2: Cautions Concerning Forward-Looking Statements
• JP Morgan Conference Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expe
Slide 3: Shaping the future of healthcare
Shaping the future of healthcare Jason Hollar Chief Executive Officer © 2025 Cardinal Health. All Rights Reserved. 3 © 2025 Cardinal Health. All Rights Reserved.
Slide 4: Healthcare's crucial link: manufacturers and providers
• JP Morgan Conference Manufacturers & Providers & Innovators Customers Biopharma innovators Generic Rx Mail order Retail and grocery manufacturers pharmacies pharmacies Consumer health Healthcare’s crucial link manufacturers Health systems Specialty physician offices Nuclear innovators Medical-surg
Slide 5: Healthcare's crucial link: upstream and downstream services
• JP Morgan Conference Upstream Downstream services services • Radiopharmaceutical • Distribution development and • GPO services commercialization services • Clinical insights • Medical manufacturing • Advanced data • 3PL and technology • Patient access services Healthcare’s crucial link solutions •
Slide 6: Positioned at the forefront of key trends
• JP Morgan Conference Positioned at the forefront of key trends Patient Pharmaceutical Site of care Technology demographics innovation shifts advancements Increasing utilization of Novel specialty Care delivery shifting to Deploying new pharmaceutical and therapies requiring more cost-effective and
Slide 7: Company snapshot
• JP Morgan Conference Company snapshot 1 $220B+ in FY25 revenue Revenue FY25 Guidance1 Segment profit Pharma & Specialty Pharma & Specialty 99%+ GMPD 92% 6% 77% of revenue generated in the U.S. Other GMPD ~$2.6B in FY25 operating earnings 2% 6% Approximately Other 48,000 employees globally 17% Othe
Slide 8: Track record of execution and value creation
• JP Morgan Conference Track record of execution and value creation FY23 + FY24 Results Total Shareholder Return FY23 to CY241 140% +138% 120% EPS +49% 100% 80% 60% +62% Operating earnings +22% 40% 20% +12% 0% 6/30/22 6/30/23 6/30/24 -20% Adj free cash flow $6.8B Cardinal Health S&P 500 S&P Healthca
Slide 9: Our continued momentum
• JP Morgan Conference Our continued momentum Updating fiscal 2025 non-GAAP EPS guidance toward High end of $7.75 to $7.90 range 9 © 2025 Cardinal Health. All Rights Reserved.
Slide 10: Strategic priorities
• JP Morgan Conference Strategic priorities Relentless focus on simplification 1 2 3 Build upon the growth and resiliency of Pharmaceutical and Specialty Solutions by expanding in Specialty Accelerate growth in key areas and shareholder value creation Execute GMPD Improvement Plan initiatives 10 © 2
Slide 11: Investing across our businesses
• JP Morgan Conference Organic growth Investing across our businesses Pharmaceutical and Specialty Solutions at-Home Solutions, NPHS and OptiFreight® Logistics Global Medical Products and Distribution • Announced 3 new state-of-the- Opening our Consumer Health Logistics Center in CY25: at-Home art d
Slide 12: Investing in high-quality assets in key strategic areas
• JP Morgan Conference Inorganic growth Investing in high-quality assets in key strategic areas Serving 11,500 specialty providers, including Adds more than 100 community oncology Platform includes over 900 physicians Serving ~500,000 patients by providing 7,000+ physicians across 1,200 practices pr
Slide 13: Supporting community-based physicians with a comprehensive model
• JP Morgan Conference Supporting community-based physicians with a comprehensive model 13 © 2025 Cardinal Health. All Rights Reserved.
Slide 14: Accelerating at-Home Solutions' strategy with the acquisition of ADSG
• JP Morgan Conference Accelerating at-Home Solutions’ strategy with the highly synergistic acquisition of ADSG Core principles of at-Home Solutions strategy Leading direct providers of medical supplies to patients in their homes We provide medical supplies direct to people + in their homes Diabetes
Slide 15: Disciplined Capital Allocation
JP Morgan Conference Table stakes FY25 Progress Investing back into the business to drive $90M in Q1 capex organic growth Disciplined Maintain investment Completed annual opioid settlement payment Capital grade balance sheet Credit ratings maintained by all 3 rating agencies post acquisition announc
Slide 16: Compelling investment thesis
• JP Morgan Conference Compelling investment thesis Moving healthcare forward Pharmaceutical and at-Home, NPHS & Medical Products Cash flow and Value Specialty Solutions OptiFreight and Distribution capital deployment creation Resilient and growing business, Favorable long-term Executing our plan to
Slide 17: Upcoming Investor Day
• JP Morgan Conference Upcoming: Featuring management including: Investor Day June 12, 2025 Jason Hollar Aaron Alt Debbie Weitzman CEO CFO Pharmaceutical & Specialty Solutions Focus areas to include: • Specialty strategy • Growth businesses • GMPD Improvement Plan • Long-term targets Rob Schlissberg
Slide 18: Appendix
Appendix 18 © 2025 Cardinal Health. All Rights Reserved. 18 © 2025 Cardinal Health. All Rights Reserved.
Slide 19: Forward Looking Non-GAAP Measures
Forward Looking Non-GAAP Measures In this presentation, the Company presents certain forward-looking non-GAAP metrics. The Company does not provide outlook on a GAAP basis because the items that the Company excludes from GAAP to calculate the comparable non-GAAP measure can be dependent on future ev
Cardinal Health — 43rd Annual J.P. Morgan Healthcare Conference 2025 on 6ix